What Is CKD-Related Low Testosterone?
Chronic kidney disease affects testosterone production in 40-60% of men on dialysis and 15-40% of those with earlier-stage CKD.1 When your estimated glomerular filtration rate (eGFR) — a measure of kidney filtering capacity — drops below 30 mL/min/1.73 m², prevalence jumps to nearly 70%.2
This isn't just about one condition causing the other. The relationship between CKD and low testosterone is bidirectional. Declining kidney function disrupts the hormonal signals that tell your testes to produce testosterone. At the same time, low testosterone worsens many CKD complications — muscle wasting, anemia, insulin resistance, and cardiovascular disease.2
Men with both conditions face significantly higher all-cause and cardiovascular mortality compared to those with CKD and normal testosterone levels.2 The good news: recognizing and addressing testosterone deficiency may improve outcomes, though treatment requires close coordination between your primary care doctor, nephrologist, and potentially an endocrinologist.
Key Takeaways
Chronic kidney disease causes low testosterone in 40-60% of men on dialysis through disruption of hormone signaling, chronic inflammation, and direct testicular damage. This bidirectional relationship worsens CKD complications including muscle wasting, anemia, and cardiovascular disease, significantly increasing mortality risk.
- Prevalence jumps to 70% when eGFR drops below 30 mL/min/1.73 m²
- Low testosterone with elevated LH indicates primary hypogonadism
- Diagnosis requires two morning testosterone measurements below 300 ng/dL
- TRT remains off-label but shows promise for improving muscle mass and anemia
- Treatment requires coordination between nephrologist, endocrinologist, and primary care
- Lifestyle interventions include resistance exercise, sleep optimization, and nutritional management
Signs and Symptoms
CKD-related hypogonadism produces a mix of physical and emotional symptoms that often overlap with kidney disease itself.
Fatigue and Energy Loss
Persistent exhaustion that doesn't improve with rest, making daily activities feel overwhelming.
Muscle Wasting and Sarcopenia
Progressive loss of muscle mass and strength, accelerating protein-energy wasting in advanced CKD.
Low Libido and Erectile Dysfunction
Reduced sexual desire and difficulty achieving or maintaining erections.
Mood Changes and Depression
Irritability, brain fog, poor concentration, and persistent low mood.
Symptom severity tracks closely with kidney function decline. Mild fatigue and reduced libido in CKD stages 1-3 often progress to debilitating muscle loss, severe anemia, and clinical depression as eGFR drops below 30.3 Patients on dialysis report the most pronounced symptoms, with testosterone deficiency compounding the physical toll of renal replacement therapy.
Many men assume these symptoms are simply part of having kidney disease. That's partially true — but testosterone deficiency makes every symptom worse. When both conditions coexist, the combined impact on quality of life, cardiovascular risk, and mortality exceeds what kidney disease alone would cause.2
Sarcopenia is the progressive loss of muscle mass and strength, often accelerated in chronic kidney disease patients due to hormonal imbalances, reduced protein synthesis, and increased protein breakdown.
How CKD Causes Low Testosterone
Kidney disease disrupts testosterone production through multiple interconnected mechanisms.
HPG Axis Disruption
The hypothalamic-pituitary-gonadal axis — your body's testosterone control system — malfunctions in CKD. Luteinizing hormone (LH) pulses from your pituitary gland become weaker and less frequent, reducing the signal that tells your testes to produce testosterone. Paradoxically, baseline LH levels often rise because low testosterone triggers compensatory feedback and because damaged kidneys clear LH poorly.1 This pattern indicates primary hypogonadism — your testes can't respond properly even when signaled.
Uremic Environment
As kidney function declines, waste products accumulate in your bloodstream. This uremic state triggers chronic inflammation marked by elevated IL-6, C-reactive protein, and fibrinogen — all of which suppress testosterone production.3 Nutritional deficiencies common in CKD further impair hormone synthesis. Your kidneys also lose their ability to clear hormones efficiently, disrupting normal feedback loops. The cumulative effect is a hostile metabolic environment for testosterone production.
Testicular Damage
CKD causes direct physical damage to testicular tissue. Biopsies show seminiferous tubule atrophy, fibrosis, and calcification in men with advanced kidney disease.1 Even when LH levels rise, your testes produce less testosterone per unit of stimulation — a blunted response confirmed in studies using human chorionic gonadotropin (hCG) testing. Testicular size often decreases as CKD progresses, reflecting ongoing structural deterioration.
Risk factors that amplify this process include declining eGFR (especially below 30 mL/min/1.73 m²), dialysis dependence, and comorbid conditions like diabetes, obesity, and hypertension.2 Each of these independently suppresses testosterone, and their combined presence in CKD creates a multiplicative effect.
The relationship runs both ways. Low testosterone worsens kidney disease outcomes by promoting insulin resistance, atherosclerosis, hypertension, and inflammation — the same pathways that caused the testosterone drop in the first place.3 This bidirectional loop makes CKD and hypogonadism particularly difficult to manage when they coexist.
Diagnosis and Lab Testing
Diagnosis starts with symptoms and confirmatory lab work. Your doctor should order a morning blood draw to measure total testosterone — the standard threshold for low testosterone is under 300 ng/dL, with a normal range of 300-1000 ng/dL.4 A single low reading isn't enough. Guidelines recommend a second confirmatory test on a different day before diagnosing hypogonadism.
Free testosterone — the biologically active portion not bound to carrier proteins — provides additional context, especially in CKD where sex hormone-binding globulin (SHBG) levels remain normal despite low total and free testosterone.2
Your doctor will also check LH and follicle-stimulating hormone (FSH) to determine whether the problem originates in your testes or brain. In CKD, you typically see low testosterone with elevated LH — a pattern indicating primary hypogonadism where your testes can't respond adequately to hormonal signals.1 Prolactin levels may be elevated in CKD and should be measured to rule out hyperprolactinemia as a contributing factor.
Inflammatory markers like interleukin-6 (IL-6) and C-reactive protein help quantify the chronic inflammation that suppresses testosterone production.3
Your eGFR stage matters. CKD stages 1-5 classify kidney function from mild (stage 1, eGFR >90) to kidney failure (stage 5, eGFR <15). Hypogonadism risk climbs steeply as you move from stage 3 to stage 4, with the highest prevalence when eGFR drops below 30.2
No validated screening questionnaires exist specifically for CKD-related low testosterone. Your doctor relies on clinical history — asking about libido, erectile function, energy levels, mood, muscle strength, and sleep quality — combined with physical examination and the lab results above.4
Treatment and Management
Managing low testosterone in CKD requires a multifaceted approach centered on both hormone replacement and the underlying kidney disease.
Testosterone Replacement Therapy
TRT shows promise for improving muscle mass, strength, anemia, inflammation, and quality of life in CKD patients, but it remains off-label for this indication. Always pursue TRT under nephrologist oversight given potential effects on kidney function and cardiovascular risk.
Resistance Exercise
Strength training preserves muscle mass and may modestly boost testosterone production. Even low-intensity resistance work helps counter sarcopenia in advanced CKD.
Nutritional Optimization
Work with a renal dietitian to balance protein intake against CKD restrictions. Address micronutrient deficiencies that impair testosterone synthesis, particularly zinc and vitamin D.
Sleep and Stress Management
Poor sleep directly suppresses testosterone production. Prioritize 7-9 hours nightly and address sleep apnea, which is common in CKD and independently lowers testosterone.
Cardiovascular Health
Control blood pressure and lipid levels aggressively. ACE inhibitors and ARBs, standard CKD treatments, may have neutral or even positive effects on testosterone levels compared to other antihypertensives.
Comorbidity Management
Optimize diabetes control, treat anemia with erythropoiesis-stimulating agents when appropriate, and address obesity through sustainable lifestyle changes. Each of these independently improves testosterone levels.
TRT Efficacy and Safety in CKD
Preliminary evidence suggests TRT may improve outcomes in CKD, but no FDA-approved protocols exist. Use remains investigational and off-label.3 Small studies show improvements in hemoglobin levels, muscle strength, bone density, and quality of life, but long-term cardiovascular safety data in CKD populations are limited.
One significant finding: hemodialysis patients with low testosterone show 5.3 times higher risk of anemia compared to those with normal levels.2 Testosterone stimulates red blood cell production through erythropoiesis and inhibits hepcidin, making TRT a potential adjunct to standard anemia management.
Monitoring Requirements
If you start TRT, your care team will monitor testosterone levels, hemoglobin, hematocrit, prostate-specific antigen (PSA), and kidney function markers every 3-6 months initially. Watch for signs of fluid retention, worsening hypertension, or accelerated CKD progression. Some patients experience a transient decline in eGFR when starting TRT, though the clinical significance remains debated.
Timeline Expectations
Symptom improvement follows a predictable sequence. Energy and mood typically improve within 3-6 weeks. Muscle strength and mass gains become noticeable around 3-6 months. Bone density and cardiovascular marker changes require at least 12 months to manifest.4
Dialysis Considerations
Men on hemodialysis face unique challenges. Dialysis sessions themselves may temporarily affect testosterone levels through fluid shifts and electrolyte changes. Some nephrologists recommend timing TRT administration relative to dialysis schedules to optimize absorption and minimize side effects. Peritoneal dialysis patients have less dramatic fluctuations but require the same careful monitoring.
The Bottom Line
TRT may improve symptoms and reduce mortality risk in men with CKD-related hypogonadism, but it requires close kidney function monitoring and collaboration between your nephrologist and prescribing physician. First-line CKD management — blood pressure control, glucose optimization, and lifestyle modification — remains essential regardless of whether you pursue hormone replacement.